The high cost of cancer drugs and what we can do about it

M Siddiqui, SV Rajkumar - Mayo Clinic Proceedings, 2012 - mayoclinicproceedings.org
Last year, ipilimumab (Yervoy; Bristol-Myers Squibb, New York, NY) was approved by the
Food and Drug Administration (FDA) for the treatment of metastatic melanoma. The benefit …

[HTML][HTML] Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy

RK Pai, RK Pai - Modern Pathology, 2018 - Elsevier
Neoadjuvant therapy is increasingly used to treat patients with a wide variety of
malignancies. Histologic evaluation of treated specimens provides important prognostic …

Current treatment options for the management of esophageal cancer

MR Mawhinney, RE Glasgow - Cancer management and research, 2012 - Taylor & Francis
In recent years, esophageal cancer characteristics and management options have evolved
significantly. There has been a sharp increase in the frequency of esophageal …

Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study

SK Bhat, DT McManus, HG Coleman, BT Johnston… - Gut, 2015 - gut.bmj.com
Objective Endoscopic surveillance of Barrett's oesophagus (BO) provides an opportunity to
detect early stage oesophageal adenocarcinoma (OAC). We sought to determine the …

Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas

HH Yoon, Q Shi, WR Sukov, AE Wiktor, M Khan… - Clinical Cancer …, 2012 - AACR
Purpose: We examined the frequency, tumor characteristics, and prognostic impact of HER2
protein expression and gene amplification in patients with curatively resected esophageal …

Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma

HH Yoon, Q Shi, WR Sukov, MA Lewis… - Journal of Clinical …, 2012 - ascopubs.org
Purpose There is increasing recognition of the existence of intratumoral heterogeneity of the
human epidermal growth factor receptor (HER2), which affects interpretation of HER2 …

The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients

M Lu, Z Yang, Q Feng, M Yu, Y Zhang, C Mao, L Shen… - Medicine, 2016 - journals.lww.com
Although signet ring cell cancer (SRCC) has long been regarded as an adverse prognostic
factor of gastric cancer, the findings of existing studies on this issue are inconsistent. We …

Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma

HH Yoon, MA Lewis, Q Shi, M Khan… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Given that smoking affects body mass index (BMI) and survival, stratification by
smoking status may be required to determine the true prognostic impact of BMI. Although …

HER‐2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma

HH Yoon, WR Sukov, Q Shi, CA Sattler, AE Wiktor… - Cancer, 2014 - Wiley Online Library
BACKGROUND Human epidermal growth factor receptor 2 (HER2) is a therapeutic target in
patients with esophageal adenocarcinoma (EAC), with gene amplification used as a …

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma

S Yendamuri, M Huang, U Malhotra, GW Warren… - Cancer, 2013 - Wiley Online Library
BACKGROUND Signet ring cell esophageal adenocarcinoma histology has been difficult to
study in single institution series because of its relative rarity, yet has an anecdotal reputation …